Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Keith Allen

Thoracic Surgery (Cardiothoracic Vascular Surgery) Kansas City, KS Medical Doctor

NPI 1609804855 CMS profile 117615

4320 Wornall Rd, Ste 50 11, Kansas City, KS 64111

Open in the dashboard

General payments

$2,044,244

1,630 records reported · program years 2019–2025

Research payments

$33,331

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$492,866 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Keith Allen of Kansas City, KS is reported in the CMS Open Payments database as having received $2,044,244 across 1,630 general payments and $33,331 in research payments paid to them. Separately, studies naming them as principal investigator received $492,866 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $289,510 299
2024 General $251,975 271
2024 Research $8,550 4
2023 General $367,038 234
2023 Research $16,031 4
2022 General $445,845 323
2021 General $279,473 148
2020 General $233,449 147
2019 General $176,954 208
2019 Research $8,750 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keith Allen
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Keith Allen were reported at $289,510. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Keith Allen Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $176,954 $886 $178–$3,167 $163
2020 $233,449 $341 $108–$1,605 $114
2021 $279,473 $453 $125–$1,886 $132
2022 $445,845 $695 $180–$2,566 $149
2023 $367,038 $745 $205–$2,662 $160
2024 $251,975 $799 $214–$2,967 $164
2025 $289,510 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $977,628 584 payments
  2. CSL Behring $323,129 48 payments
  3. Zimmer Biomet Holdings, Inc. $251,607 453 payments
  4. Abbott Laboratories $214,650 242 payments
  5. Medtronic, Inc. $213,531 225 payments
  6. Pi-Cardia, Inc. $18,525 1 payment
  7. CVRx, Inc. $9,750 1 payment
  8. Medtronic Vascular, Inc. $8,135 18 payments
  9. Silk Road Medical, Inc. $6,842 5 payments
  10. Aziyo Biologics, Inc. $5,942 4 payments
  11. Other $14,505 49 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,577,547 500 payments
  2. Travel and Lodging $212,695 523 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $194,989 86 payments
  4. Food and Beverage $30,812 495 payments
  5. Education $19,375 18 payments
  6. Honoraria $7,676 7 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $1,150 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $817,430 333 payments
  2. COREVALVE EVOLUT R $209,115 195 payments
  3. Edwards SAPIEN 3 Transcatheter Heart Valve $139,905 154 payments
  4. SternaLock Blu $52,606 60 payments
  5. SternaLock 360 $32,490 25 payments
  6. A&E MEDICAL / STERNALOCK XP RIGID FIXATION SYSTEM $29,589 46 payments
  7. STERNALOCK 360 SYSTEM $26,571 39 payments
  8. STERNALOCK BLU SYSTEM $26,533 52 payments
  9. NAVITOR $26,448 24 payments
  10. Shortcut $18,525 1 payment
  11. Other $173,339 413 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. CryoLife, Inc. $24,581 8 payments
  2. Abbott Laboratories $5,250 1 payment
  3. Zimmer Biomet Holdings, Inc. $3,500 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Cardiac Surgery: 68

Drug cost

$76

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 11 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$107,396

Medicare's payments for the services billed

Medicare patients

253

Average age 79

Services billed

461

109 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 74%
Atrial fibrillation 63%
Chronic kidney disease 49%
Arthritis 49%
Diabetes 42%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,642 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record